These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2508227

  • 1. Recombinant tissue plasminogen activator: implications in therapy.
    Topol EJ.
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):25-31. PubMed ID: 2508227
    [Abstract] [Full Text] [Related]

  • 2. [Thrombolytic drugs in acute myocardial infarct].
    Ambrosioni E, Degli Esposti D.
    Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796
    [Abstract] [Full Text] [Related]

  • 3. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Adv Exp Med Biol; 1990 Dec; 281():333-54. PubMed ID: 2129372
    [Abstract] [Full Text] [Related]

  • 4. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D, Bounameaux H.
    Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
    [Abstract] [Full Text] [Related]

  • 5. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W, Schmutzler H.
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [Abstract] [Full Text] [Related]

  • 6. Tissue plasminogen activator: a new thrombolytic agent.
    Crabbe SJ, Cloninger CC.
    Clin Pharm; 1987 May; 6(5):373-86. PubMed ID: 3117481
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Development of new thrombolytic substances].
    Zeymer U, Neuhaus KL.
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [Abstract] [Full Text] [Related]

  • 12. Fibrinolytic agents: mechanisms of activity and pharmacology.
    Lijnen HR, Collen D.
    Thromb Haemost; 1995 Jul; 74(1):387-90. PubMed ID: 8578491
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M, Bory M, Collen D, Erbel R, Lennane RJ, Mathey D, Michels HR, Schartl M, Uebis R, Bernard R.
    Klin Wochenschr; 1988 Jul; 66 Suppl 12():77-85. PubMed ID: 3126348
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
    Bell WR.
    Rev Cardiovasc Med; 2002 Jul; 3 Suppl 2():S34-44. PubMed ID: 12556741
    [Abstract] [Full Text] [Related]

  • 17. [Tissue-type plasminogen activator].
    Turazza FM, Pogna M.
    Medicina (Firenze); 1990 Jul; 10(1):75-8. PubMed ID: 2116566
    [Abstract] [Full Text] [Related]

  • 18. Combinations of thrombolytic agents in acute myocardial infarction.
    Bode C, Baumann H, von Hodenberg E, Freitag M, Nordt T.
    Z Kardiol; 1993 Jul; 82 Suppl 2():125-8. PubMed ID: 8328189
    [Abstract] [Full Text] [Related]

  • 19. New developments in thrombolytic therapy.
    Collen DC, Gold HK.
    Thromb Res Suppl; 1990 Jul; 10():105-31. PubMed ID: 2180114
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.